Amcasertib(BBI503)
Cat. No.: DC10372
Featured
Chemical Structure
1129403-56-0
We are official vendor of:
More than 5000 active chemicals with high quality for research!
Field of application
Amcasertib(BBI503) is an orally administered investigational agent designed to inhibit cancer stem cell pathways, including Nanog, by targeting stemness kinases.
| Cas No.: |
1129403-56-0 |
| Chemical Name: |
Amcasertib |
| Synonyms: |
AMCASERTIB;BBI503;Amcasertib (BBI503);s8572;A16850;N-[2-(Diethylamino)ethyl]-2,4-dimethyl-5-[(E)-[2-oxo-5-(2-phenyl-1,3-thiazol-4-yl)-1H-indol-3-yliden;Amcasertib |
| SMILES: |
S1C(C2C([H])=C([H])C([H])=C([H])C=2[H])=NC(=C1[H])C1C([H])=C([H])C2=C(C=1[H])/C(/C(N2[H])=O)=C(/[H])\C1=C(C([H])([H])[H])C(C(N([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])=O)=C(C([H])([H])[H])N1[H] |
| Formula: |
C31H33N5O2S |
| M.Wt: |
539.6910 |
| Purity: |
>98% |
| Sotrage: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
Amcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways, including Nanog, by targeting stemness kinases. |
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
| 2018-0101 |
|
Get Quote
